CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Restricted stock units | −17,175 | 34,350 | ||
| 2021-03-01 | Ruffo Frank Chief Financial Officer | Option exercise | +25,750 | 240,939 | ||
| 2021-03-01 | Ruffo Frank Chief Financial Officer | Shares withheld for taxes | −7,333 | $24.06 | $176K | 233,606 |
| 2021-03-01 | Ruffo Frank Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +116,000 | 116,000 | ||
| 2021-03-01 | Ruffo Frank Chief Financial Officer | Grant or award · Restricted stock units | +33,200 | 33,200 | ||
| 2021-03-01 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted stock units | −25,750 | 51,500 | ||
| 2021-03-01 | Walker Neal President and CEO | Option exercise | +96,150 | 1,251,948 | ||
| 2021-03-01 | Walker Neal President and CEO | Shares withheld for taxes | −39,792 | $24.06 | $957K | 1,212,156 |
| 2021-03-01 | Walker Neal President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +255,800 | 255,800 | ||
| 2021-03-01 | Walker Neal President and CEO | Grant or award · Restricted stock units | +73,100 | 73,100 | ||
| 2021-03-01 | Walker Neal President and CEO | Option exercise · Restricted stock units | −96,150 | 192,300 | ||
| 2021-02-02 | Mehra Anand Director | Option exercise | +8,000 | $18.35 | $147K | 24,209 |
| 2021-02-02 | Mehra Anand Director | Option exercise | +6,632 | $18.32 | $121K | 30,841 |
| 2021-02-02 | Mehra Anand Director | Option exercise · Option Grant (right to buy) | −8,000 | 0 | ||
| 2021-02-02 | Mehra Anand Director | Option exercise · Option Grant (right to buy) | −6,632 | 0 | ||
| 2021-02-01 | Ruffo Frank Chief Financial Officer | Option exercise | +3,875 | 216,497 | ||
| 2021-02-01 | Ruffo Frank Chief Financial Officer | Shares withheld for taxes | −1,308 | $21.35 | $28K | 215,189 |
| 2021-02-01 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted Stock Units | −3,875 | 3,875 | ||
| 2021-02-01 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +3,875 | 127,964 | ||
| 2021-02-01 | Ali-Jackson Kamil Chief Legal Officer | Shares withheld for taxes | −1,318 | $21.35 | $28K | 126,646 |
Page 33 of 34 · 680 trades